Factors affecting the efficacy of botulinum toxin injection in the treatment of infantile and partially accommodative esotropia

被引:0
作者
Alarfaj, Motazz A. [1 ,2 ]
Alsarhani, Waleed K. [3 ,4 ]
Alrashed, Saleh H. [5 ]
Alarfaj, Faris A. [1 ]
Ahmad, Khabir [6 ]
Awad, Abdulaziz [1 ]
Sesma, Gorka [1 ,7 ]
机构
[1] King Khalid Eye Specialist Hosp, Pediat Ophthalmol & Strabismus Div, Riyadh, Saudi Arabia
[2] Imam Abdulrahman Bin Faisal Univ, Dept Ophthalmol, Dammam, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Ophthalmol, Riyadh, Saudi Arabia
[4] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada
[5] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh, Saudi Arabia
[6] King Khalid Eye Specialist Hosp, Dept Res, Riyadh, Saudi Arabia
[7] King Khalid Eye Specialist Hosp, Pediat Ophthalmol & Strabismus Div, Al Urubah Branche Rd,West Bldg,2nd Floor, Riyadh 11462, Saudi Arabia
关键词
Accommodative esotropia; botulinum toxin; infantile esotropia; strabismus; ACQUIRED ESOTROPIA; DOSE INCREMENTS; FOLLOW-UP; STRABISMUS; SURGERY; COMPLICATIONS; REOPERATION; RETREATMENT; MANAGEMENT; CHILDREN;
D O I
10.4103/meajo.meajo_39_23
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: We aimed to investigate the effect of botulinum toxin (BT) injection on the treatment of infantile and partially accommodative esotropia (PAET). METHODS: This retrospective cohort study included patients who received BT injections for infantile and PAET between January 2015 and December 2018. Treatment was considered successful if orthotropia, consecutive exotropia, or esotropia within 10 prism diopters (PD) was achieved. RESULTS: The overall success rate was 47.4%, with a mean follow-up period of 27.8 months in 403 children. BT treatment was considered successful in 37.1% of cases of infantile esotropia and 53.1% of cases of partially accommodative esotropia. The average deviation angle before starting treatment was 35.5 +/- 13.9 PD. Side effects 1 week after BT injections included transient overcorrection (63.8%) and transient ptosis (41.7%). There were no significant differences in the success rates between the different doses of BT (P = 0.69). The angle of deviation at presentation was significantly associated with the success rate of BT injection (failed group, mean: 38.1 +/- 15.3 PD vs. success group, mean: 32.6 +/- 11.6 PD; P < 0.001). Other factors associated with higher success rates were overcorrection at 1 week and PAET, while multivariate logistic regression analysis showed that a smaller angle of deviation and overcorrection (1 week after injection) were associated with a higher success rate. CONCLUSION: A smaller angle of deviation and transient overcorrection were associated with a higher success rate, and no significant difference was observed in the success rates of different BT doses.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 27 条
[1]   Factors influencing success and dose-effect relation of botulinum A treatment [J].
Abbasoglu, OE ;
Sener, EC ;
Sanac, AS .
EYE, 1996, 10 :385-391
[2]   The Efficacy of Dose Increments of Botulinum Toxin A in the Treatment of Childhood Esotropia [J].
Alshamlan, Fatemah T. ;
Al Abdulhadi, Halla A. ;
Alwalmany, Mofi M. ;
Alotaibi, Khalid S. .
CLINICAL OPHTHALMOLOGY, 2021, 15 :113-120
[3]   Clinical Outcomes of Botulinum Toxin Injection in Patients with Cerebral Palsy and Esotropia [J].
Ameri, Ahmad ;
Mirmohammadsadeghi, Arash ;
Makateb, Ali ;
Bazvand, Fatemeh ;
Hosseini, Simindokht .
STRABISMUS, 2015, 23 (01) :8-13
[4]   Treatment of congenital esotropia with botulinum toxin type A [J].
Baggesen, Kirsten ;
Arnljot, Havard Magnus .
ACTA OPHTHALMOLOGICA, 2011, 89 (05) :484-488
[5]  
BIGLAN AW, 1989, OPHTHALMOLOGY, V96, P935
[6]  
BURNS CL, 1986, OPHTHALMOLOGY, V93, P1621
[7]   Comparison of botulinum toxin with surgery as primary treatment for infantile esotropia [J].
Campomanes, Alejandra G. de Alba ;
Binenbaum, Gil ;
Campomanes Eguiarte, Glorialicia .
JOURNAL OF AAPOS, 2010, 14 (02) :111-116
[8]  
Campos EC, 2000, J PEDIAT OPHTH STRAB, V37, P328
[9]  
Cronemberger Mônica Fialho, 2006, Arq. Bras. Oftalmol., V69, P523, DOI 10.1590/S0004-27492006000400013
[10]   Botulinum toxin in ophthalmology [J].
Dutton, Jonathan J. ;
Fowler, Amy M. .
SURVEY OF OPHTHALMOLOGY, 2007, 52 (01) :13-31